Tweedy Browne Co LLC Decreases Stock Holdings in Haleon plc (NYSE:HLN)

Tweedy Browne Co LLC reduced its stake in shares of Haleon plc (NYSE:HLN) by 4.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 110,478 shares of the company’s stock after selling 5,288 shares during the quarter. Tweedy Browne Co LLC’s holdings in Haleon were worth $938,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in HLN. Hexagon Capital Partners LLC boosted its holdings in Haleon by 107.3% in the fourth quarter. Hexagon Capital Partners LLC now owns 4,236 shares of the company’s stock worth $35,000 after acquiring an additional 2,193 shares in the last quarter. Pinnacle Bancorp Inc. boosted its holdings in Haleon by 853.4% in the fourth quarter. Pinnacle Bancorp Inc. now owns 4,767 shares of the company’s stock worth $39,000 after acquiring an additional 4,267 shares in the last quarter. Allspring Global Investments Holdings LLC acquired a new stake in Haleon in the first quarter worth about $43,000. Tower Research Capital LLC TRC boosted its holdings in Haleon by 146.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,398 shares of the company’s stock worth $44,000 after acquiring an additional 3,211 shares in the last quarter. Finally, SRS Capital Advisors Inc. boosted its holdings in Haleon by 456.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 5,458 shares of the company’s stock worth $45,000 after acquiring an additional 4,477 shares in the last quarter. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Haleon Stock Performance

HLN stock traded up $0.11 during trading on Friday, hitting $8.91. 1,299,697 shares of the company traded hands, compared to its average volume of 5,264,483. The stock’s 50-day simple moving average is $8.43 and its 200 day simple moving average is $8.37. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.04 and a quick ratio of 0.73. The company has a market cap of $40.68 billion, a PE ratio of 29.32, a P/E/G ratio of 2.51 and a beta of 0.24. Haleon plc has a 1 year low of $7.70 and a 1 year high of $8.96.

Haleon (NYSE:HLN) last issued its quarterly earnings data on Wednesday, May 1st. The company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.11 by $0.01. Haleon had a return on equity of 13.17% and a net margin of 9.68%. The company had revenue of $3.70 billion for the quarter, compared to analyst estimates of $3.71 billion. On average, equities analysts expect that Haleon plc will post 0.46 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Argus reissued a “buy” rating on shares of Haleon in a report on Tuesday, March 26th. Berenberg Bank assumed coverage on Haleon in a report on Wednesday, June 5th. They issued a “buy” rating for the company. Finally, HSBC assumed coverage on Haleon in a research note on Wednesday, April 17th. They issued a “buy” rating for the company. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, Haleon presently has an average rating of “Moderate Buy”.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.